ISOThrive
Healdsburg, California, United States · Biopharma, Biotechnology, Healthcare
ISOThrive Inc. is a clinical-stage biopharmaceutical company that is developing novel, microbiome-targeted therapeutics for gastrointestinal diseases. Its lead product, ISOT-101, is a first-in-class treatment being evaluated for Non-Erosive Reflux Disease (NERD). The company focuses on addressing significant unmet medical needs in this area.
Key facts
- Headquarters
- Healdsburg, California, United States
- Employees
- Unknown
- Industries
- Biopharma, Biotechnology, Healthcare
- Status
- Private
- Website
- isothrive.com
- Company page
Recent activity at ISOThrive
- : ISOThrive
- : ISOThrive Inc. Appoints Mike Walther as Chief Strategy Officer
- : ISOThrive Inc.
- : IsoThrive Inc.
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
ISOThrive funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2025 | Venture | $8.1M |
| Feb 2021 | Venture | $5.2M |
| Nov 2019 | Venture | $4.0M |
Leadership
- Jack Oswald, Executive Officer, Director
- Alyn Oswald, Director
- James Farrell, Director
- Fadi Karam, Director
- Mike Walther, Director
- Peter Swann, Founder
Verified email and direct lines for ISOThrive’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
ISOThrive in the news
Companies similar to ISOThrive
- Corvus Pharmaceuticals, Inc. · Biopharma, Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
- Praxis Precision Medicines, Inc. · Biopharma, Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
- Longboard Pharmaceuticals · Biopharma, Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
- vTv Therapeutics Inc. · Biopharma, Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
- Mereo Biopharma Group plc · Biopharma, Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
About ISOThrive: questions and answers
What does ISOThrive do?
ISOThrive Inc. is a clinical-stage biopharmaceutical company that is developing novel, microbiome-targeted therapeutics for gastrointestinal diseases. Its lead product, ISOT-101, is a first-in-class treatment being evaluated for Non-Erosive Reflux Disease (NERD). The company focuses on addressing significant unmet medical needs in this area.
Where is ISOThrive headquartered?
ISOThrive is headquartered in Healdsburg, California, United States.
Has ISOThrive raised funding?
Yes. Fundz has recorded 3 funding events for ISOThrive. The most recent, $8.1M, was in Oct 2025.
Who leads ISOThrive?
Peter Swann is a Founder at ISOThrive.
What is the latest news on ISOThrive?
On Oct 10, 2025, ISOThrive
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy